On April 13, 2023, a panel of the Inquiry Committee approved a Consent Agreement between BCCNM and the Registrant to address issues that occurred between October 2020 and January 2022 related to diverting narcotics from wastage for personal use on and off duty. The Registrant disclosed the diversion from the workplace on their own accord when seeking treatment. This disclosure ensured that their medical diagnosis and subsequent prognosis and treatment recommendations matched the extent of their substance use disorder, providing a greater likelihood of treatment success. The extent of the disclosure was considered mitigating by the Inquiry Committee. The Registrant was diagnosed with and admitted to a disability with a causal relationship to the practice issues via an independent medical report and has agreed to comply with treatment recommendations.
The Registrant has voluntarily agreed to terms equivalent to limits and/or conditions on their practice, including:
- Compliance with treatment and monitoring recommendations of their treating specialist;
- Disclosure of treatment recommendations to relevant employer representative(s);
- Limits restricting the Registrant's access to and handling of narcotics, with concurrent medical monitoring, to support the stable return to fitness to practice;
- Limits on working overtime and night shifts; and
- Remedial education related to ethics and professionalism in nursing.
The Agreement will remain in place for a minimum of four years of continuous nursing practice.
The name of the Registrant has been withheld in accordance with section 39.3 (4) (a) of the Health Professions Act for the purposes of not identifying the personal health information of the Registrant respecting the condition.
The Inquiry Committee is satisfied that the terms will protect the public.